Literature DB >> 27512064

Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.

Hans P Verkerke1, James A Williams1, Miklos Guttman1, Cassandra A Simonich2, Yu Liang1, Modestas Filipavicius1, Shiu-Lok Hu3, Julie Overbaugh2, Kelly K Lee4.   

Abstract

UNLABELLED: Soluble forms of trimeric HIV-1 envelope glycoprotein (Env) have long been sought as immunogens and as reagents for analysis of Env structure and function. Isolation of trimers that mimic native Env, derived from diverse viruses, however, represents a major challenge. Thus far, the most promising native-like (NL) structures have been obtained by engineering trimer-stabilizing mutations, termed SOSIP, into truncated Env sequences. However, the abundances of NL trimeric conformers vary among Envs, necessitating purification by monoclonal antibodies (MAbs) like PGT145, which target specific epitopes. To surmount this inherent limitation, we developed an approach that uses lectin affinity chromatography, ion-exchange chromatography, hydrophobic-interaction chromatography (HIC), and size exclusion chromatography (SEC) to isolate NL trimers from nonnative Env species. We validated this method with SOSIP trimers from HIV-1 clades A and B. Analyses by SEC, blue native PAGE, SDS-PAGE, and dynamic light scattering indicated that the resulting material was homogeneous (>95% pure), fully cleaved, and of the appropriate molecular weight and size for SOSIP trimers. Negative-stain electron microscopy further demonstrated that our preparations were composed of NL trimeric structures. By hydrogen/deuterium-exchange mass spectrometry, these HIC-pure trimers exhibited structural organization consistent with NL trimers and inconsistent with profiles seen in nonnative Envs. Screened for antigenicity, some Envs, like BS208.b1 and KNH1144 T162A, did not present the glycan/quaternary structure-dependent epitope for PGT145 binding, suggesting that these SOSIPs would be challenging to isolate by existing MAb affinity methods. By selecting based on biochemical rather than antigenic properties, our method offers an epitope-independent alternative to MAbs for isolation of NL Env trimers. IMPORTANCE: The production and purification of diverse soluble Env trimers that maintain native-like (NL) structure present technical challenges that must be overcome in order to advance vaccine development and provide reagents for HIV research. Low levels of NL trimer expression amid heterogeneous Env conformers, even with the addition of stabilizing mutations, have presented a major challenge. In addition, it has been difficult to separate the NL trimers from these heterogeneous mixtures. While MAbs with specificity for quaternary NL trimer epitopes have provided one approach to purifying the desirable species, such methods are dependent on the Env displaying the proper epitope. In addition, MAb affinity chromatography can be expensive, the necessary MAb may be in limited supply, and large-scale purification may not be feasible. Our method based on biochemical separation techniques offers an epitope-independent approach to purification of NL trimers with general application to diverse Envs.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27512064      PMCID: PMC5044855          DOI: 10.1128/JVI.01351-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Leash in the groove mechanism of membrane fusion.

Authors:  Heather E Park; Jennifer A Gruenke; Judith M White
Journal:  Nat Struct Biol       Date:  2003-11-02

2.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

3.  Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.

Authors:  Jean-Philippe Julien; Jeong Hyun Lee; Albert Cupo; Charles D Murin; Ronald Derking; Simon Hoffenberg; Michael J Caulfield; C Richter King; Andre J Marozsan; Per Johan Klasse; Rogier W Sanders; John P Moore; Ian A Wilson; Andrew B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

4.  Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.

Authors:  Lei Chen; Young Do Kwon; Tongqing Zhou; Xueling Wu; Sijy O'Dell; Lisa Cavacini; Ann J Hessell; Marie Pancera; Min Tang; Ling Xu; Zhi-Yong Yang; Mei-Yun Zhang; James Arthos; Dennis R Burton; Dimiter S Dimitrov; Gary J Nabel; Marshall R Posner; Joseph Sodroski; Richard Wyatt; John R Mascola; Peter D Kwong
Journal:  Science       Date:  2009-11-20       Impact factor: 47.728

5.  HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.

Authors:  Cassandra A Simonich; Katherine L Williams; Hans P Verkerke; James A Williams; Ruth Nduati; Kelly K Lee; Julie Overbaugh
Journal:  Cell       Date:  2016-06-23       Impact factor: 41.582

6.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.

Authors:  Rajesh P Ringe; Rogier W Sanders; Anila Yasmeen; Helen J Kim; Jeong Hyun Lee; Albert Cupo; Jacob Korzun; Ronald Derking; Thijs van Montfort; Jean-Philippe Julien; Ian A Wilson; Per Johan Klasse; Andrew B Ward; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

7.  Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.

Authors:  Jean-Philippe Julien; Jeong Hyun Lee; Gabriel Ozorowski; Yuanzi Hua; Alba Torrents de la Peña; Steven W de Taeye; Travis Nieusma; Albert Cupo; Anila Yasmeen; Michael Golabek; Pavel Pugach; P J Klasse; John P Moore; Rogier W Sanders; Andrew B Ward; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

8.  CD4-induced activation in a soluble HIV-1 Env trimer.

Authors:  Miklos Guttman; Natalie K Garcia; Albert Cupo; Tsutomu Matsui; Jean-Philippe Julien; Rogier W Sanders; Ian A Wilson; John P Moore; Kelly K Lee
Journal:  Structure       Date:  2014-06-12       Impact factor: 5.006

9.  Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.

Authors:  Kwinten Sliepen; Gabriel Ozorowski; Judith A Burger; Thijs van Montfort; Melissa Stunnenberg; Celia LaBranche; David C Montefiori; John P Moore; Andrew B Ward; Rogier W Sanders
Journal:  Retrovirology       Date:  2015-09-26       Impact factor: 4.602

10.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

View more
  24 in total

1.  Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.

Authors:  Yu Liang; Miklos Guttman; James A Williams; Hans Verkerke; Daniel Alvarado; Shiu-Lok Hu; Kelly K Lee
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.

Authors:  Eden P Go; Haitao Ding; Shijian Zhang; Rajesh P Ringe; Nathan Nicely; David Hua; Robert T Steinbock; Michael Golabek; James Alin; S Munir Alam; Albert Cupo; Barton F Haynes; John C Kappes; John P Moore; Joseph G Sodroski; Heather Desaire
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 3.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

4.  An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes.

Authors:  Adam S Dingens; Dana Arenz; Haidyn Weight; Julie Overbaugh; Jesse D Bloom
Journal:  Immunity       Date:  2019-01-29       Impact factor: 31.745

5.  Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.

Authors:  Thandeka Moyo; June Ereño-Orbea; Rajesh Abraham Jacob; Clara E Pavillet; Samuel Mundia Kariuki; Emily N Tangie; Jean-Philippe Julien; Jeffrey R Dorfman
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

6.  Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.

Authors:  Reda Rawi; Lucy Rutten; Yen-Ting Lai; Adam S Olia; Sven Blokland; Jarek Juraszek; Chen-Hsiang Shen; Yaroslav Tsybovsky; Raffaello Verardi; Yongping Yang; Baoshan Zhang; Tongqing Zhou; Gwo-Yu Chuang; Peter D Kwong; Johannes P M Langedijk
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

7.  Quadrivalent influenza nanoparticle vaccines induce broad protection.

Authors:  Seyhan Boyoglu-Barnum; Daniel Ellis; Rebecca A Gillespie; Geoffrey B Hutchinson; Young-Jun Park; Syed M Moin; Oliver J Acton; Rashmi Ravichandran; Mike Murphy; Deleah Pettie; Nick Matheson; Lauren Carter; Adrian Creanga; Michael J Watson; Sally Kephart; Sila Ataca; John R Vaile; George Ueda; Michelle C Crank; Lance Stewart; Kelly K Lee; Miklos Guttman; David Baker; John R Mascola; David Veesler; Barney S Graham; Neil P King; Masaru Kanekiyo
Journal:  Nature       Date:  2021-03-24       Impact factor: 69.504

8.  A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.

Authors:  Krishana Gulla; Nicole Cibelli; Jonathan W Cooper; Haley C Fuller; Zachary Schneiderman; Sara Witter; Yaqiu Zhang; Anita Changela; Hui Geng; Christian Hatcher; Sandeep Narpala; Yaroslav Tsybovsky; Baoshan Zhang; Adrian B McDermott; Peter D Kwong; Daniel B Gowetski
Journal:  Vaccine       Date:  2021-05-18       Impact factor: 4.169

9.  Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.

Authors:  Daniel Ellis; Natalie Brunette; Katharine H D Crawford; Alexandra C Walls; Minh N Pham; Chengbo Chen; Karla-Luise Herpoldt; Brooke Fiala; Michael Murphy; Deleah Pettie; John C Kraft; Keara D Malone; Mary Jane Navarro; Cassandra Ogohara; Elizabeth Kepl; Rashmi Ravichandran; Claire Sydeman; Maggie Ahlrichs; Max Johnson; Alyssa Blackstone; Lauren Carter; Tyler N Starr; Allison J Greaney; Kelly K Lee; David Veesler; Jesse D Bloom; Neil P King
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

10.  cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.

Authors:  Antu K Dey; Albert Cupo; Gabriel Ozorowski; Vaneet K Sharma; Anna-Janina Behrens; Eden P Go; Thomas J Ketas; Anila Yasmeen; Per J Klasse; Eddy Sayeed; Heather Desaire; Max Crispin; Ian A Wilson; Rogier W Sanders; Thomas Hassell; Andrew B Ward; John P Moore
Journal:  Biotechnol Bioeng       Date:  2017-12-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.